Pancreatic Cancer Research

ResearcherUNSW SydneyActive in the last 2 years

Jeremy S. Wilson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2355-8632; OpenAlex author ID A5031151434. Sources: OpenAlex.

Their work

Papers
26 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
50
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 3 papers · 2015: 1 paper · 2016: 3 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 5 papers · 2021: 3 papers · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 26

  1. Lipid cargo of exosomes derived from pancreatic stellate cells and cancer cells: Role in pancreatic cancer-related diabetes. Co-author DOI 10.1016/j.bbalip.2026.159736↗
  2. Selective Urokinase Inhibition Plus Chemotherapy: A Novel Approach to Pancreatic Cancer Treatment via Enhanced Antitumor Immunity and Decreased Metastasis. Co-author DOI 10.1053/j.gastro.2025.07.021↗
  3. Proteomic profiling of small extracellular vesicles derived from mouse pancreatic cancer and stellate cells: Role in pancreatic cancer. Co-author DOI 10.1002/pmic.202300067↗
  4. Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer. Co-author DOI 10.1016/j.bbcan.2022.188728↗
  5. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). Co-author DOI 10.3389/fimmu.2022.1060957↗
  6. Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications. Co-author DOI 10.1016/j.pan.2020.11.022↗
  7. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer. Co-author DOI 10.3390/cancers13112763↗
  8. Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis. Co-author DOI 10.3390/cancers13205224↗
  9. Pancreatic stellate cells: Aiding and abetting pancreatic cancer progression. Co-author DOI 10.1016/j.pan.2020.01.003↗
  10. Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis. Co-author DOI 10.1038/s41416-020-0782-1↗
  11. Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and el… Co-author DOI 10.1038/s41416-020-1004-6↗
  12. Targeting HGF/c-MET Axis in Pancreatic Cancer. Co-author DOI 10.3390/ijms21239170↗
  13. An Orthotopic Resectional Mouse Model of Pancreatic Cancer. Co-author DOI 10.3791/61726↗
  14. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/path.5224↗
  15. Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research. Co-author DOI 10.1093/carcin/bgx030↗
  16. Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer. Co-author DOI 10.18632/oncotarget.20822↗
  17. Key role of pancreatic stellate cells in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2015.10.035↗
  18. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer. Co-author DOI 10.1038/bjc.2015.478↗
  19. Pancreatic cancer: A multipronged approach to pancreatic cancer treatment. First author DOI 10.1038/nrgastro.2016.75↗
  20. Pancreatic cancer: The microenvironment needs attention too! Last author DOI 10.1016/j.pan.2015.02.013↗
  21. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Co-author DOI 10.1016/j.cell.2014.08.007↗
  22. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic can… Last author DOI 10.1093/carcin/bgu122↗
  23. Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression. Co-author DOI 10.3389/fphys.2014.00052↗
  24. A starring role for stellate cells in the pancreatic cancer microenvironment. First author DOI 10.1053/j.gastro.2012.11.037↗
  25. The burning question: why is smoking a risk factor for pancreatic cancer? Co-author DOI 10.1016/j.pan.2012.06.002↗
  26. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells. First author DOI 10.1111/j.1440-1746.2011.07000.x↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Minoti Vivek Apte · 26 shared papers, 2012–2026 · strength 2.96
  2. Zhihong Xu · 16 shared papers, 2014–2026 · strength 1.93
  3. Chamini Jayamali Perera · 7 shared papers, 2020–2026 · strength 1.30
  4. David Goldstein · 13 shared papers, 2014–2022 · strength 1.28
  5. Srinivasa P. Pothula · 12 shared papers, 2014–2021 · strength 1.16
  6. Tony Pang · 7 shared papers, 2017–2026 · strength 0.96
  7. S. M. Zahid Hosen · 3 shared papers, 2022–2026 · strength 0.59
  8. Marie Ranson · 2 shared papers, 2022–2026 · strength 0.39
  9. Suresh T. Chari · 2 shared papers, 2021–2024 · strength 0.34
  10. Marco Falasca · 2 shared papers, 2021–2024 · strength 0.34
  11. Helen Barong Binang · 1 shared paper, 2026 · strength 0.29
  12. Rohit Sarkar · 1 shared paper, 2026 · strength 0.29
  13. Ashna A. Kumar · 1 shared paper, 2026 · strength 0.26
  14. Lily M. Channon · 1 shared paper, 2022 · strength 0.17
  15. Mohammad Ali Moni · 1 shared paper, 2022 · strength 0.13
  16. Steve Gallinger · 1 shared paper, 2022 · strength 0.13
  17. Faiyaz Notta · 1 shared paper, 2022 · strength 0.13
  18. Takashi Murakami · 1 shared paper, 2020 · strength 0.11
  19. Stephen Jacob Pandol · 2 shared papers, 2012–2013 · strength 0.09
  20. Neil Donald Merrett · 1 shared paper, 2017 · strength 0.08
  21. Annemilaï Tijeras‐Raballand · 1 shared paper, 2019 · strength 0.08
  22. Cindy Neuzillet · 1 shared paper, 2019 · strength 0.08
  23. Anguraj Sadanandam · 1 shared paper, 2019 · strength 0.08
  24. Corinne Bousquet · 1 shared paper, 2019 · strength 0.08
  25. Mert Erkan · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.